Loring Wolcott & Coolidge Fiduciary Advisors’s Aemetis AMTX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMTX
Loring Wolcott & Coolidge Fiduciary Advisors's AMTX Position: Q2 2025 in Review
Loring Wolcott & Coolidge Fiduciary Advisors sold out of Aemetis (AMTX) in Q2 2025, closing a stake of 6,961 shares — an estimated $9.61K sold.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in AMTX in Q1 2025 and held it in 1 quarter. The position peaked at $9.61K in Q1 2025. 71 funds tracked by Wall St. Rank hold AMTX as of Q2 2025.
- Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Aemetis position as of Q2 2025 after selling out during the quarter.
- Loring Wolcott & Coolidge Fiduciary Advisors sold 6,961 Aemetis shares in Q2 2025, an estimated $9.61K.
- Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Aemetis in Q1 2025 and held it in 1 quarter.
- Loring Wolcott & Coolidge Fiduciary Advisors's Aemetis position peaked at $9.61K in Q1 2025.
- 71 funds tracked by Wall St. Rank held Aemetis as of Q2 2025.
Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2025, filed 30 Jul 2025.